Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-04

FDA Approved: MIDODRINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Midodrine hydrochloride submitted by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine hydrochloride (Midodrine hydrochloride)

Snippet

SUPPL AP for MIDODRINE HYDROCHLORIDE (MIDODRINE HYDROCHLORIDE)